Skip to Content Skip to Content

Health & Medicine

New tools to treat retinal degenerations at advanced stages of disease
Raghavi Sudharsan and William Beltran by a microscope in a lab.

Raghavi Sudharsan and William Beltran of the Division of Experimental Retinal Therapies at Penn’s School of Veterinary Medicine.

nocred

New tools to treat retinal degenerations at advanced stages of disease

A collaborative team of researchers led by vision scientists at the School of Veterinary Medicine have developed novel promoters that drive strong and specific gene expression in rod and cone photoreceptors in mid-to-late stages of disease, potentially offering new and improved options for gene therapy.

3 min. read

Neurobowl reimagines how the next generation of neurologists is trained
Sashank Prasad and Raymond Price.

Sashank Prasad (left), chief of Neurology at Penn Presbyterian Medical Center, and Raymond Price, chief of Neurology at Pennsylvania Hospital.

(Image: Courtesy of Penn Medicine News)

Neurobowl reimagines how the next generation of neurologists is trained

Sashank Prasad and Raymond Price have collaborated for years on an online quiz-show to teach uncommon neurological conditions for Penn Medicine students, and have introduced the program to other institutions as well.

From Penn Medicine News

World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration
Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ in the hospital.

Penn Medicine’s Kiran Musunuru and Rebecca Ahrens-Nicklas holding KJ post infusion.

(Image: Courtesy of Children’s Hospital of Philadelphia)

World’s first patient treated with personalized CRISPR gene editing therapy through CHOP and Penn Med collaboration

A landmark study from CHOP and Penn Medicine showcases the power of customized gene editing therapy to treat a patient with a rare metabolic disease

Matt Toal

5 min. read

American Dental Association and Penn Dental Medicine announce first Living Guideline Program in oral health
(Left to right) Olivia Urquhart, Michael Glick, and Alonso Carrasco-Labra.

(Left to right) Olivia Urquhart, Michael Glick, and Alonso Carrasco-Labra of Penn Dental’s Center for Integrative Global Oral Health (CIGOH).

(Image: Kevin Monko)

American Dental Association and Penn Dental Medicine announce first Living Guideline Program in oral health

The groundbreaking program will provide evidence-informed guidelines in real time to support patient care and advance public health.

2 min. read

A mothers’ meetup like no other for families formed through uterus transplant
Two people embrace at a uterine transplant meetup lunch with a baby in a stroller and gifts on a conference table.

Image: Courtesy of Penn Medicine News

A mothers’ meetup like no other for families formed through uterus transplant

One week before Mother’s Day, those who gave birth through uterus transplant gathered for a special brunch with those who donated their uteruses for the procedure, and their respective families.

Alex Gardner

2 min. read

Promising inhibitor combination for hard-to-treat leukemia subtypes
Andres Blanco in a lab at Penn Vet.

Andrés Blanco is an assistant professor of biomedical science at Penn’s School of Veterinary Medicine.

(Image: John Donges)

Promising inhibitor combination for hard-to-treat leukemia subtypes

Researchers from Penn Vet and other institutions have identified a novel inhibitor combination of molecules that induce terminal differentiation for the treatment of human non-APL subtypes of AML.

From Penn Vet

2 min. read